Colony Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-500
Closed -$39K 750
2015
Q4
$39K Hold
500
﹤0.01% 510
2015
Q3
$35K Sell
500
-2,517
-83% -$207K ﹤0.01% 500
2015
Q2
$272K Buy
3,017
+335
+12% +$32.3K 0.03% 312
2015
Q1
$270K Sell
2,682
-87
-3% -$8.77K 0.03% 263
2014
Q4
$278K Buy
2,769
+20
+0.7% +$1.99K 0.03% 300
2014
Q3
$265K Buy
2,749
+1,437
+110% +$136K 0.03% 291
2014
Q2
$122K Buy
1,312
+406
+45% +$35.5K 0.02% 257
2014
Q1
$75K Sell
906
-3,220
-78% -$261K 0.01% 290
2013
Q4
$346K Sell
4,126
-90,060
-96% -$7.33M 0.05% 177
2013
Q3
$6.99M Sell
94,186
-6,469
-6% -$485K 1.38% 35
2013
Q2
$7.97M Buy
+100,655
New +$8.07M 1.59% 33

Other funds holding MJN

Colony Group's MJN Position: Q1 2016 in Review

Colony Group sold out of Mead Johnson Nutrition Company (MJN) in Q1 2016, closing a stake of 500 shares — an estimated $39K sold.

Colony Group first reported a position in MJN in Q2 2013 and held it in 11 quarters. The position peaked at $7.97M in Q2 2013. 562 funds tracked by Wall St. Rank hold MJN as of Q1 2016.

  • Colony Group reported no remaining Mead Johnson Nutrition Company position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 500 Mead Johnson Nutrition Company shares in Q1 2016, an estimated $39K.
  • Colony Group first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 11 quarters.
  • Colony Group's Mead Johnson Nutrition Company position peaked at $7.97M in Q2 2013.
  • 562 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.